#MemberHighlight - Biweekly newsletter of the International Cytokine & Interferon Society

Member Highlight Interview: Rosa Nguyen

November 18, 2024

My lab focuses on the development of novel immunotherapies for pediatric solid tumors. We take the most promising discoveries and translate them into the clinic. [READ MORE]

Collage of photos featuring Curt Horvath

New President’s Message: A Quarter-Century Journey with The Cytokine Society

December 1, 2025

As I write this first contribution to Signals as President of THE CYTOKINE SOCIETY, I find myself thinking about my 25 years of involvement with this organization. What a long, strange trip it has been from my first Cytokine meeting in Amsterdam in 2000, a joint meeting of our parent [READ MORE]

Meet Dominic Ritacco: Exploring Cellular Self-Defense Against Chagas Disease

November 30, 2025

I am a fourth-year Ph.D. candidate in the Gaudet Lab at Columbia University. My research revolves around the idea that non-immune cells can protect themselves against pathogens through effector interferon-stimulated genes (ISGs). Many of these ISGs are poorly characterized, and I am exploring the role of these genes in Chagas [READ MORE]

IL-1 Inhibition in Early TNBC (OZM-034)

November 30, 2025

ClinicalTrials.gov ID NCT06710197 Sponsor University Health Network, Toronto Information provided by University Health Network, Toronto (Responsible Party) Last Update Posted 2025-03-11 Study Overview Brief Summary This study will examine changes in the tumor microenvironment (TME) induced by 14 days of pre-operative IL-1-inhibiting therapy among patients with early breast cancer (including [READ MORE]

Biological, Prospective Study Evaluating the Dosage of Plasma Cytokines Including the FLT3 Ligand and IL6 of Patients Treated With Non-intensive Chemotherapy (CYTOK-AZA)

November 30, 2025

ClinicalTrials.gov ID NCT06439199 Sponsor Nantes University Hospital Information provided by Nantes University Hospital (Responsible Party) Last Update Posted 2024-09-27 Study Overview Brief Summary There are 2 possible treatments for the treatment of Acute Myelogenous Leukemia (AML), high-risk myelodysplastic syndromes (HR-MDS) or chronic myelomonocytic leukemia (CMML): intensive curative chemotherapy , and [READ MORE]

The Effect of Intrathecal Morphine and Erector Spina Plan Block on Serum Cytokine Levels and Chronic Pain in Caesarean Section Surgery

November 30, 2025

ClinicalTrials.gov ID NCT06684015 Sponsor Ankara University Information provided by Fatih Kurt, Ankara University (Responsible Party) Last Update Posted 2024-11-12 Study Overview Brief Summary Working Title The Effect of Intrathecal Morphine and Erector Spina Plan Block on Serum Cytokine Levels and Chronic Pain in Caesarean Section Surgery Study Description This study [READ MORE]

Share this: